SG/CALL/STRYKER CORP./300/0.1/21.06.24 Stock

Warrant

DE000SQ4VR52

Delayed Deutsche Boerse AG 01:20:19 2024-06-13 pm EDT
3.99 EUR -9.11% Intraday chart for SG/CALL/STRYKER CORP./300/0.1/21.06.24
Current month+8.42%
1 month+59.60%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-13 3.99 -9.11%
24-06-12 4.39 +2.57%
24-06-11 4.28 -4.25%
24-06-10 4.47 -1.97%
24-06-07 4.56 +1.33%

Delayed Quote Deutsche Boerse AG

Last update June 13, 2024 at 01:20 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ4VR5
ISINDE000SQ4VR52
Date issued 2022-11-25
Strike 300 $
Maturity 2024-06-21 (7 Days)
Parity 10 : 1
Emission price 1.68
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.01
Lowest since issue 1.02

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
343 USD
Average target price
372.5 USD
Spread / Average Target
+8.59%
Consensus